HEMATIM, EA4666, CURS, CHU Amiens Sud, Avenue René Laënnec, Salouel, F-80054 Amiens, France.
INSERM U1148, Laboratory for Vascular Translational Science (LVTS), UFR SMBH, Université Paris 13-Sorbonne Paris Cité, 93017 Bobigny CEDEX, France.
Int J Mol Sci. 2018 Dec 24;20(1):67. doi: 10.3390/ijms20010067.
TRIpartite motif (TRIM) proteins are part of the largest subfamilies of E3 ligases that mediate the transfer of ubiquitin to substrate target proteins. In this review, we focus on TRIM37 in the normal cell and in pathological conditions, with an emphasis on the MULIBREY (MUscle-LIver-BRain-EYe) genetic disorder caused by mutations. TRIM37 is characterized by the presence of a RING domain, B-box motifs, and a coiled-coil region, and its C-terminal part includes the MATH domain specific to TRIM37. MULIBREY nanism is a rare autosomal recessive caused by mutations and characterized by severe pre- and postnatal growth failure. Constrictive pericarditis is the most serious anomaly of the disease and is present in about 20% of patients. The patients have a deregulation of glucose and lipid metabolism, including type 2 diabetes, fatty liver, and hypertension. Puzzlingly, MULIBREY patients, deficient for TRIM37, are plagued with numerous tumors. Among non-MULIBREY patients affected by cancer, a wide variety of cancers are associated with an overexpression of TRIM37. This suggests that normal cells need an optimal equilibrium in TRIM37 expression. Finding a way to keep that balance could lead to potential innovative drugs for MULIBREY nanism, including heart condition and carcinogenesis treatment.
三基序蛋白(TRIM)是 E3 连接酶最大亚家族的一部分,可介导泛素向底物靶蛋白的转移。在这篇综述中,我们重点关注正常细胞和病理条件下的 TRIM37,特别强调由 突变引起的 MULIBREY(肌肉-肝脏-大脑-眼睛)遗传疾病。TRIM37 的特征是存在一个 RING 结构域、B-box 基序和一个卷曲螺旋区,其 C 末端部分包括 TRIM37 特有的 MATH 结构域。MULIBREY 矮小症是一种罕见的常染色体隐性遗传疾病,由 突变引起,其特征是严重的产前和产后生长发育迟缓。缩窄性心包炎是该病最严重的异常,约 20%的患者存在。患者存在葡萄糖和脂质代谢失调,包括 2 型糖尿病、脂肪肝和高血压。令人费解的是,缺乏 TRIM37 的 MULIBREY 患者患有许多肿瘤。在患有癌症的非 MULIBREY 患者中,与 TRIM37 过表达相关的各种癌症都存在。这表明正常细胞需要 TRIM37 表达的最佳平衡。找到保持这种平衡的方法可能会为 MULIBREY 矮小症,包括心脏状况和癌症发生的治疗,带来潜在的创新药物。